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in 39.7%. OSA was classified as mild (OSA-M) in 30.4% and as moderate
to severe (OSA-S) in 69.6%. After a median follow-up of 75 months (IQR
71-79), patients with OSA-S showed a significantly higher incidence of
the composite endpoint (relative risk 3.29, 95% CI 1.07-10.10; p=0.038).
Kapplan-Meier survival curves are represented in Figure 1. Adherence to
CPAP was 42.9% and there was a numerically lower proportion of patients
with composite endpoint in the group of compliant patients (33.3% vs.
37.5%, p=NS). 
Conclusions OSA has a high prevalence in ACS patients. Its screening has
high diagnostic yield and allows to identify patients with clearly unfavorable
prognosis and a potentially treatable risk factor. CPAP notes a significant
number of noncompliant, but may improve prognosis, justifying further ran-
domized clinical studies.
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Obesity is an independent risk factor for coronary artery disease and
premature death. However, a number of studies have demonstrated that it
is inversely associated with short-term mortality in patients with acute cor-
onary artery disease. Most data suggesting this “obesity paradox” identify
obesity with body mass index (BMI), but weight was not previously con-
sidered while it could be an alternative measurement that may also prove
to be an accurate predictor of in-hospital mortality. The aim of this study
was to determine whether BMI and weight are related to in-hospital mor-
tality in patients admitted for an acute coronary syndrome (ACS). Data
was derived from the EURHOBOP cohort, a multicenter ACS hospital reg-
istry conducted between 2008 and 2010 in 7 European countries. ACS
patients with discharge diagnosis of myocardial infarction or unstable
angina were included. Socio-demographic characteristics, medical histo-
ries and acute episodes at entry or during hospitalization were recorded.
In-hospital mortality risk by BMI or weight categories were assessed using
multiple logistic regression. A total of 6298 patients were included. Mean
age was 65.3±12.7 years, 75% were men, 27% had diabetes and 63% had
hypertension. ST-elevation ACS was observed in 31% of patients. BMI
ranged from 13.4 to 64.5kg/m2; 46% were overweight (25≤BMI<30) and
24% obese (BMI≥30). Weight ranged from 36 to 190kg. Mortality rate
was 3.1% [95% CI:2.7%-3.5%]. Based on ROC curves, optimal cutoff
points to predict in-hospital survival were 26kg/m2 for BMI and 75kg for
weight. In univariate logistic regression, BMI≥26kg/m2 (OR=0.69; [95%
CI]:0.52-0.92) or weight≥75kg (OR=0.57;[95% CI]:0.43-0.76) had a sig-
nificant protective association with mortality. However, none of these
associations remained significant in multivariate analysis. In EURHOBOP,
higher BMI and weight in ACS patients were not associated with better
short term in-hospital mortality.
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Background High-degree atrioventricular block (HAVB) is a common
complication of ST-segment elevation myocardial infarction (STEMI). HAVB
in STEMI is historically considered as a marker of worse outcome but overall
data about HAVB in the contemporary era of mechanical reperfusion and
potent antiplatelet therapies are scarce.
Aim We aimed at analyzing incidence, clinical correlates and impact on in-
hospital outcomes of HAVB in a large prospective registry (ORBI) of modern
management of STEMI with a special focus on potential differences between
patients with HAVB on admission and those who developed HAVB during
hospitalization.
Methods All patients enrolled in ORBI between June 2006 and December
2013 were included in the present analysis and were divided into 3 groups:
patients without HAVB at any time, patients with HAVB on admission and
those who developed HAVB during hospitalization. 
Results 6662 patients (age: 62.0 [52.0-74.0]; male: 76.3%) were
included in the present analysis. HAVB was documented in 3.5% of
patients, present on admission in 63.7% of patients and occurring during
hospitalization in 36.3%. Patients with HAVB on admission or occurring
during the first 24h of hospitalization had higher in-hospital mortality rates
(18.1% and 28.6% respectively) than patients without (4.5%) or with
HAVB occurring beyond the first 24h of hospitalization (8.0%). However
by multivariable analysis, HAVB was not independently associated with
in-hospital mortality. 
Conclusion Patients with HAVB had a higher mortality rate than patients
without. However HAVB is not an independent predictor of in-hospital mortality. 
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Background Contrast induced nephrotoxicity (CIN) after coronary angiog-
raphy or angioplasty (CA) has been shown to be related to mortality. The rate and
predictors of CIN when preventive measures are applied are poorly documented.
Methods All consecutive patients submitted to non-urgent CA in 2014 with
low-osmolar contrast medium were stratified for CIN risk: patients with renal
dysfunction (defined as eGFR<60mL/min) had interruption of diuretics and
received a 250-500mL intravenous saline infusion before and after CA. Serum
Creatinine (SCr) levels were measured before CA and daily thereafter up to 5
days after CA. CIN was defined as an absolute increase of 44 μmol/L SCr or
of 25% over baseline SCr level. Predictors of CIN and of recovery were deter-
mined by logistic regression. CIN patients had clinical follow-up for death or
end-stage renal dysfunction.
Results SCr results were available in 958 patients, 72% male, 25% dia-
betics, median eGFR was 71mL/min before CA (interquartiles (IQ) =54; 89).
Median amount of contrast was 129mL (IQ=90; 186). At 2-4 days, CIN was
observed in 188(20%), driven by a 25% increase in SCr (n=185, 19%)
whereas 81 (8.5%) had an increase of >44mmol/L in SCr. CIN rate was
related to quartiles of eGFR before CA: 20% when eGFR<53, 14% for eGFR
between 53 and 88 and 30% for eGFR>87ml/min. The amount of contrast
medium was not a predictor of CIN. In patients without renal dysfunction, a
lower SCr was a predictor of CIN. Conversely, in patients with renal dysfunc-
tion, older age and diabetes were associated with CIN (figure).
Conclusions In contemporary routine practice, CIN occurs in 20%, driven
by a relative 25% increase in SCr, and irrespective of the amount of contrast
medium. In patients with renal dysfunction, older age and diabetes were asso-
ciated with CIN.
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Background Early infarct-related artery (IRA) patency is associated with
better clinical outcomes in STEMI patients. Using the FAST-MI 2010 ST-ele-
vation myocardial infarction (STEMI) cohort, we investigated factors related
to IRA patency (TIMI 2/3 flow) at the start of procedure in patients admitted
for primary percutaneous coronary intervention (PCI).
Methods and results FAST-MI 2010 is a nationwide French registry
including 4,169 Acute MI patients. Of 1452 STEMI patients with primary
PCI, 466 (32%) had TIMI 2/3 flow of IRA before the procedure. Mean age
(62±14 years in both groups), GRACE score (141±31 vs 142±34) and time
from onset to angiography (472±499 vs 451±479min) did not differ according
to IRA patency (TIMI2/3 vs TIMI 0/1). Using multivariate logistic regression
analysis, IRA patency was more frequently found in patients having called
earlier (<75min, median time from symptom onset: OR: 1.60; 95% CI 1.26-
2.04), or receiving antiplatelet therapy (APT) before angiography. Increasing
time from diagnostic ECG to angiography was also associated with IRA
patency (>90min, OR: 1,38; 95%IC 1.08-1.77). The results were confirmed by
propensity score analyses.
Conclusion Pre-procedural IRA patency is observed in one third of STEMI
patients; it is more frequently found in patients having received APT prior to
angiography, as well as in patients having called early. Higher IRA patency
with increasing time delays from qualifying ECG to angiography suggests an
additional role of spontaneous or medication-mediated fibrinolysis.
The author declares a conflict of interest: Fees for lectures and/or con-
sulting: Astra-Zeneca, Bayer, Daiichi-Sankyo, Lilly, MSD, The Medicine
Company, Servier. 
Sex
Age
Sex
Diabetes mellitus
Sudden cardiac death
Anterior STEMI
Reperfusion therapy
Cardiogenic shock
Mechanical ventilation
Sustained Ventricular
arrhythmias
Any Mechanical
complication
HAVB
Age
Sex
Diabetes mellitus
Sudden cardiac death
Anterior STEMI
Reperfusion therapy
Cardiogenic shock
Mechanical ventilation
Sustained Ventricular
arrhythmias
Any Mechanical
complication
HAVB
0.1 1 10 0.1 1 10
OR (95% CI)
1.060 [1.047-1.073]
1.096 [0.800-1.501]
1.381 [0.907-2.103]
4.852 [2.810-8.379]
1.569 [1.168-2.106]
0.440 [0.305-0.635]
17.981 [13.096-24.688]
3.698 [2.416-5.659]
2.514 [1.705-3.707]
3.045 [2.120-4.373]
0.993 [0.595-1.657]
<0.001
p-value
0.569
0.132
<0.001
0.003
<0.001
<0.001
<0.001
<0.001
<0.001
0.977
A B
HR [95%CI] p-value
1.042 [1.031-1.053]
1.156 [0.900-1.0486]
1.059 [0.754-1.487]
2.075 [1.541-2.661]
1.527 [1.205-1.935]
0.675 [0.505-0.902]
11.245 [8.327-15.186]
1.936 [1.422-2.637]
1.617 [1.219-2.146]
2.025 [1.542-2.661]
0.977 [0.662-1.442]
<0.001
0.257
0.740
<0.001
<0.001
0.008
<0.001
<0.001
0.001
<0.001
0.907
Abstract 0019 – Figure: Multivariable analysis
